
Global Preclinical Imaging Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Page: 95
Published Date: 18 Jul 2025
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Preclinical Imaging market size was valued at US$ 2255 million in 2024 and is forecast to a readjusted size of USD 3453 million by 2031 with a CAGR of 6.3% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.

According to our (Global Info Research) latest study, the global Preclinical Imaging market size was valued at US$ 2255 million in 2024 and is forecast to a readjusted size of USD 3453 million by 2031 with a CAGR of 6.3% during review period.
Unit: US$ M
www.globalinforesearch.com
Business Risk & Industry Analysis Reports
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations.
In 2018, the global preclinical imaging market is expected to be dominated by North America. A number of factors such as robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems are driving the growth of the preclinical imaging market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2018 to 2023. This is primarily due to the continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries.
This report is a detailed and comprehensive analysis for global Preclinical Imaging market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Preclinical Imaging market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Preclinical Imaging market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Preclinical Imaging market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Preclinical Imaging market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Preclinical Imaging
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Preclinical Imaging market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Perkinelmer, Bruker, Fujifilm, Mediso, Milabs, MR Solutions, Aspect Imaging, Li-Cor Biosciences, Trifoil Imaging, Miltenyi Biotec, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Preclinical Imaging market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Optical Imaging Systems
Nuclear Imaging Systems
Micro-MRI Systems
Micro-Ultrasound Systems
Micro-CT Systems
Preclinical Photoacoustic Imaging Systems
Preclinical Magnetic Particle Imaging (MPI) Systems
Market segment by Application
Hospitals
Diagnostics Centers
Others
Major players covered
Perkinelmer
Bruker
Fujifilm
Mediso
Milabs
MR Solutions
Aspect Imaging
Li-Cor Biosciences
Trifoil Imaging
Miltenyi Biotec
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Preclinical Imaging product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Preclinical Imaging, with price, sales quantity, revenue, and global market share of Preclinical Imaging from 2020 to 2025.
Chapter 3, the Preclinical Imaging competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Preclinical Imaging breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Preclinical Imaging market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Preclinical Imaging.
Chapter 14 and 15, to describe Preclinical Imaging sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Preclinical Imaging Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Optical Imaging Systems
1.3.3 Nuclear Imaging Systems
1.3.4 Micro-MRI Systems
1.3.5 Micro-Ultrasound Systems
1.3.6 Micro-CT Systems
1.3.7 Preclinical Photoacoustic Imaging Systems
1.3.8 Preclinical Magnetic Particle Imaging (MPI) Systems
1.4 Market Analysis by Application
1.4.1 Overview: Global Preclinical Imaging Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Diagnostics Centers
1.4.4 Others
1.5 Global Preclinical Imaging Market Size & Forecast
1.5.1 Global Preclinical Imaging Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Preclinical Imaging Sales Quantity (2020-2031)
1.5.3 Global Preclinical Imaging Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Perkinelmer
2.1.1 Perkinelmer Details
2.1.2 Perkinelmer Major Business
2.1.3 Perkinelmer Preclinical Imaging Product and Services
2.1.4 Perkinelmer Preclinical Imaging Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Perkinelmer Recent Developments/Updates
2.2 Bruker
2.2.1 Bruker Details
2.2.2 Bruker Major Business
2.2.3 Bruker Preclinical Imaging Product and Services
2.2.4 Bruker Preclinical Imaging Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Bruker Recent Developments/Updates
2.3 Fujifilm
2.3.1 Fujifilm Details
2.3.2 Fujifilm Major Business
2.3.3 Fujifilm Preclinical Imaging Product and Services
2.3.4 Fujifilm Preclinical Imaging Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Fujifilm Recent Developments/Updates
2.4 Mediso
2.4.1 Mediso Details
2.4.2 Mediso Major Business
2.4.3 Mediso Preclinical Imaging Product and Services
2.4.4 Mediso Preclinical Imaging Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Mediso Recent Developments/Updates
2.5 Milabs
2.5.1 Milabs Details
2.5.2 Milabs Major Business
2.5.3 Milabs Preclinical Imaging Product and Services
2.5.4 Milabs Preclinical Imaging Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Milabs Recent Developments/Updates
2.6 MR Solutions
2.6.1 MR Solutions Details
2.6.2 MR Solutions Major Business
2.6.3 MR Solutions Preclinical Imaging Product and Services
2.6.4 MR Solutions Preclinical Imaging Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 MR Solutions Recent Developments/Updates
2.7 Aspect Imaging
2.7.1 Aspect Imaging Details
2.7.2 Aspect Imaging Major Business
2.7.3 Aspect Imaging Preclinical Imaging Product and Services
2.7.4 Aspect Imaging Preclinical Imaging Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Aspect Imaging Recent Developments/Updates
2.8 Li-Cor Biosciences
2.8.1 Li-Cor Biosciences Details
2.8.2 Li-Cor Biosciences Major Business
2.8.3 Li-Cor Biosciences Preclinical Imaging Product and Services
2.8.4 Li-Cor Biosciences Preclinical Imaging Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Li-Cor Biosciences Recent Developments/Updates
2.9 Trifoil Imaging
2.9.1 Trifoil Imaging Details
2.9.2 Trifoil Imaging Major Business
2.9.3 Trifoil Imaging Preclinical Imaging Product and Services
2.9.4 Trifoil Imaging Preclinical Imaging Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Trifoil Imaging Recent Developments/Updates
2.10 Miltenyi Biotec
2.10.1 Miltenyi Biotec Details
2.10.2 Miltenyi Biotec Major Business
2.10.3 Miltenyi Biotec Preclinical Imaging Product and Services
2.10.4 Miltenyi Biotec Preclinical Imaging Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Miltenyi Biotec Recent Developments/Updates
3 Competitive Environment: Preclinical Imaging by Manufacturer
3.1 Global Preclinical Imaging Sales Quantity by Manufacturer (2020-2025)
3.2 Global Preclinical Imaging Revenue by Manufacturer (2020-2025)
3.3 Global Preclinical Imaging Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Preclinical Imaging by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Preclinical Imaging Manufacturer Market Share in 2024
3.4.3 Top 6 Preclinical Imaging Manufacturer Market Share in 2024
3.5 Preclinical Imaging Market: Overall Company Footprint Analysis
3.5.1 Preclinical Imaging Market: Region Footprint
3.5.2 Preclinical Imaging Market: Company Product Type Footprint
3.5.3 Preclinical Imaging Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Preclinical Imaging Market Size by Region
4.1.1 Global Preclinical Imaging Sales Quantity by Region (2020-2031)
4.1.2 Global Preclinical Imaging Consumption Value by Region (2020-2031)
4.1.3 Global Preclinical Imaging Average Price by Region (2020-2031)
4.2 North America Preclinical Imaging Consumption Value (2020-2031)
4.3 Europe Preclinical Imaging Consumption Value (2020-2031)
4.4 Asia-Pacific Preclinical Imaging Consumption Value (2020-2031)
4.5 South America Preclinical Imaging Consumption Value (2020-2031)
4.6 Middle East & Africa Preclinical Imaging Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Preclinical Imaging Sales Quantity by Type (2020-2031)
5.2 Global Preclinical Imaging Consumption Value by Type (2020-2031)
5.3 Global Preclinical Imaging Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Preclinical Imaging Sales Quantity by Application (2020-2031)
6.2 Global Preclinical Imaging Consumption Value by Application (2020-2031)
6.3 Global Preclinical Imaging Average Price by Application (2020-2031)
7 North America
7.1 North America Preclinical Imaging Sales Quantity by Type (2020-2031)
7.2 North America Preclinical Imaging Sales Quantity by Application (2020-2031)
7.3 North America Preclinical Imaging Market Size by Country
7.3.1 North America Preclinical Imaging Sales Quantity by Country (2020-2031)
7.3.2 North America Preclinical Imaging Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Preclinical Imaging Sales Quantity by Type (2020-2031)
8.2 Europe Preclinical Imaging Sales Quantity by Application (2020-2031)
8.3 Europe Preclinical Imaging Market Size by Country
8.3.1 Europe Preclinical Imaging Sales Quantity by Country (2020-2031)
8.3.2 Europe Preclinical Imaging Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Preclinical Imaging Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Preclinical Imaging Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Preclinical Imaging Market Size by Region
9.3.1 Asia-Pacific Preclinical Imaging Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Preclinical Imaging Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Preclinical Imaging Sales Quantity by Type (2020-2031)
10.2 South America Preclinical Imaging Sales Quantity by Application (2020-2031)
10.3 South America Preclinical Imaging Market Size by Country
10.3.1 South America Preclinical Imaging Sales Quantity by Country (2020-2031)
10.3.2 South America Preclinical Imaging Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Preclinical Imaging Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Preclinical Imaging Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Preclinical Imaging Market Size by Country
11.3.1 Middle East & Africa Preclinical Imaging Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Preclinical Imaging Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Preclinical Imaging Market Drivers
12.2 Preclinical Imaging Market Restraints
12.3 Preclinical Imaging Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Preclinical Imaging and Key Manufacturers
13.2 Manufacturing Costs Percentage of Preclinical Imaging
13.3 Preclinical Imaging Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Preclinical Imaging Typical Distributors
14.3 Preclinical Imaging Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables Table 1. Global Preclinical Imaging Consumption Value by Type, (USD Million), 2020 & 2024 & 2031 Table 2. Global Preclinical Imaging Consumption Value by Application, (USD Million), 2020 & 2024 & 2031 Table 3. Perkinelmer Basic Information, Manufacturing Base and Competitors Table 4. Perkinelmer Major Business Table 5. Perkinelmer Preclinical Imaging Product and Services Table 6. Perkinelmer Preclinical Imaging Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 7. Perkinelmer Recent Developments/Updates Table 8. Bruker Basic Information, Manufacturing Base and Competitors Table 9. Bruker Major Business Table 10. Bruker Preclinical Imaging Product and Services Table 11. Bruker Preclinical Imaging Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 12. Bruker Recent Developments/Updates Table 13. Fujifilm Basic Information, Manufacturing Base and Competitors Table 14. Fujifilm Major Business Table 15. Fujifilm Preclinical Imaging Product and Services Table 16. Fujifilm Preclinical Imaging Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 17. Fujifilm Recent Developments/Updates Table 18. Mediso Basic Information, Manufacturing Base and Competitors Table 19. Mediso Major Business Table 20. Mediso Preclinical Imaging Product and Services Table 21. Mediso Preclinical Imaging Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 22. Mediso Recent Developments/Updates Table 23. Milabs Basic Information, Manufacturing Base and Competitors Table 24. Milabs Major Business Table 25. Milabs Preclinical Imaging Product and Services Table 26. Milabs Preclinical Imaging Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 27. Milabs Recent Developments/Updates Table 28. MR Solutions Basic Information, Manufacturing Base and Competitors Table 29. MR Solutions Major Business Table 30. MR Solutions Preclinical Imaging Product and Services Table 31. MR Solutions Preclinical Imaging Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 32. MR Solutions Recent Developments/Updates Table 33. Aspect Imaging Basic Information, Manufacturing Base and Competitors Table 34. Aspect Imaging Major Business Table 35. Aspect Imaging Preclinical Imaging Product and Services Table 36. Aspect Imaging Preclinical Imaging Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 37. Aspect Imaging Recent Developments/Updates Table 38. Li-Cor Biosciences Basic Information, Manufacturing Base and Competitors Table 39. Li-Cor Biosciences Major Business Table 40. Li-Cor Biosciences Preclinical Imaging Product and Services Table 41. Li-Cor Biosciences Preclinical Imaging Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 42. Li-Cor Biosciences Recent Developments/Updates Table 43. Trifoil Imaging Basic Information, Manufacturing Base and Competitors Table 44. Trifoil Imaging Major Business Table 45. Trifoil Imaging Preclinical Imaging Product and Services Table 46. Trifoil Imaging Preclinical Imaging Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 47. Trifoil Imaging Recent Developments/Updates Table 48. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors Table 49. Miltenyi Biotec Major Business Table 50. Miltenyi Biotec Preclinical Imaging Product and Services Table 51. Miltenyi Biotec Preclinical Imaging Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 52. Miltenyi Biotec Recent Developments/Updates Table 53. Global Preclinical Imaging Sales Quantity by Manufacturer (2020-2025) & (K Units) Table 54. Global Preclinical Imaging Revenue by Manufacturer (2020-2025) & (USD Million) Table 55. Global Preclinical Imaging Average Price by Manufacturer (2020-2025) & (USD/Unit) Table 56. Market Position of Manufacturers in Preclinical Imaging, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024 Table 57. Head Office and Preclinical Imaging Production Site of Key Manufacturer Table 58. Preclinical Imaging Market: Company Product Type Footprint Table 59. Preclinical Imaging Market: Company Product Application Footprint Table 60. Preclinical Imaging New Market Entrants and Barriers to Market Entry Table 61. Preclinical Imaging Mergers, Acquisition, Agreements, and Collaborations Table 62. Global Preclinical Imaging Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR Table 63. Global Preclinical Imaging Sales Quantity by Region (2020-2025) & (K Units) Table 64. Global Preclinical Imaging Sales Quantity by Region (2026-2031) & (K Units) Table 65. Global Preclinical Imaging Consumption Value by Region (2020-2025) & (USD Million) Table 66. Global Preclinical Imaging Consumption Value by Region (2026-2031) & (USD Million) Table 67. Global Preclinical Imaging Average Price by Region (2020-2025) & (USD/Unit) Table 68. Global Preclinical Imaging Average Price by Region (2026-2031) & (USD/Unit) Table 69. Global Preclinical Imaging Sales Quantity by Type (2020-2025) & (K Units) Table 70. Global Preclinical Imaging Sales Quantity by Type (2026-2031) & (K Units) Table 71. Global Preclinical Imaging Consumption Value by Type (2020-2025) & (USD Million) Table 72. Global Preclinical Imaging Consumption Value by Type (2026-2031) & (USD Million) Table 73. Global Preclinical Imaging Average Price by Type (2020-2025) & (USD/Unit) Table 74. Global Preclinical Imaging Average Price by Type (2026-2031) & (USD/Unit) Table 75. Global Preclinical Imaging Sales Quantity by Application (2020-2025) & (K Units) Table 76. Global Preclinical Imaging Sales Quantity by Application (2026-2031) & (K Units) Table 77. Global Preclinical Imaging Consumption Value by Application (2020-2025) & (USD Million) Table 78. Global Preclinical Imaging Consumption Value by Application (2026-2031) & (USD Million) Table 79. Global Preclinical Imaging Average Price by Application (2020-2025) & (USD/Unit) Table 80. Global Preclinical Imaging Average Price by Application (2026-2031) & (USD/Unit) Table 81. North America Preclinical Imaging Sales Quantity by Type (2020-2025) & (K Units) Table 82. North America Preclinical Imaging Sales Quantity by Type (2026-2031) & (K Units) Table 83. North America Preclinical Imaging Sales Quantity by Application (2020-2025) & (K Units) Table 84. North America Preclinical Imaging Sales Quantity by Application (2026-2031) & (K Units) Table 85. North America Preclinical Imaging Sales Quantity by Country (2020-2025) & (K Units) Table 86. North America Preclinical Imaging Sales Quantity by Country (2026-2031) & (K Units) Table 87. North America Preclinical Imaging Consumption Value by Country (2020-2025) & (USD Million) Table 88. North America Preclinical Imaging Consumption Value by Country (2026-2031) & (USD Million) Table 89. Europe Preclinical Imaging Sales Quantity by Type (2020-2025) & (K Units) Table 90. Europe Preclinical Imaging Sales Quantity by Type (2026-2031) & (K Units) Table 91. Europe Preclinical Imaging Sales Quantity by Application (2020-2025) & (K Units) Table 92. Europe Preclinical Imaging Sales Quantity by Application (2026-2031) & (K Units) Table 93. Europe Preclinical Imaging Sales Quantity by Country (2020-2025) & (K Units) Table 94. Europe Preclinical Imaging Sales Quantity by Country (2026-2031) & (K Units) Table 95. Europe Preclinical Imaging Consumption Value by Country (2020-2025) & (USD Million) Table 96. Europe Preclinical Imaging Consumption Value by Country (2026-2031) & (USD Million) Table 97. Asia-Pacific Preclinical Imaging Sales Quantity by Type (2020-2025) & (K Units) Table 98. Asia-Pacific Preclinical Imaging Sales Quantity by Type (2026-2031) & (K Units) Table 99. Asia-Pacific Preclinical Imaging Sales Quantity by Application (2020-2025) & (K Units) Table 100. Asia-Pacific Preclinical Imaging Sales Quantity by Application (2026-2031) & (K Units) Table 101. Asia-Pacific Preclinical Imaging Sales Quantity by Region (2020-2025) & (K Units) Table 102. Asia-Pacific Preclinical Imaging Sales Quantity by Region (2026-2031) & (K Units) Table 103. Asia-Pacific Preclinical Imaging Consumption Value by Region (2020-2025) & (USD Million) Table 104. Asia-Pacific Preclinical Imaging Consumption Value by Region (2026-2031) & (USD Million) Table 105. South America Preclinical Imaging Sales Quantity by Type (2020-2025) & (K Units) Table 106. South America Preclinical Imaging Sales Quantity by Type (2026-2031) & (K Units) Table 107. South America Preclinical Imaging Sales Quantity by Application (2020-2025) & (K Units) Table 108. South America Preclinical Imaging Sales Quantity by Application (2026-2031) & (K Units) Table 109. South America Preclinical Imaging Sales Quantity by Country (2020-2025) & (K Units) Table 110. South America Preclinical Imaging Sales Quantity by Country (2026-2031) & (K Units) Table 111. South America Preclinical Imaging Consumption Value by Country (2020-2025) & (USD Million) Table 112. South America Preclinical Imaging Consumption Value by Country (2026-2031) & (USD Million) Table 113. Middle East & Africa Preclinical Imaging Sales Quantity by Type (2020-2025) & (K Units) Table 114. Middle East & Africa Preclinical Imaging Sales Quantity by Type (2026-2031) & (K Units) Table 115. Middle East & Africa Preclinical Imaging Sales Quantity by Application (2020-2025) & (K Units) Table 116. Middle East & Africa Preclinical Imaging Sales Quantity by Application (2026-2031) & (K Units) Table 117. Middle East & Africa Preclinical Imaging Sales Quantity by Country (2020-2025) & (K Units) Table 118. Middle East & Africa Preclinical Imaging Sales Quantity by Country (2026-2031) & (K Units) Table 119. Middle East & Africa Preclinical Imaging Consumption Value by Country (2020-2025) & (USD Million) Table 120. Middle East & Africa Preclinical Imaging Consumption Value by Country (2026-2031) & (USD Million) Table 121. Preclinical Imaging Raw Material Table 122. Key Manufacturers of Preclinical Imaging Raw Materials Table 123. Preclinical Imaging Typical Distributors Table 124. Preclinical Imaging Typical Customers List of Figures Figure 1. Preclinical Imaging Picture Figure 2. Global Preclinical Imaging Revenue by Type, (USD Million), 2020 & 2024 & 2031 Figure 3. Global Preclinical Imaging Revenue Market Share by Type in 2024 Figure 4. Optical Imaging Systems Examples Figure 5. Nuclear Imaging Systems Examples Figure 6. Micro-MRI Systems Examples Figure 7. Micro-Ultrasound Systems Examples Figure 8. Micro-CT Systems Examples Figure 9. Preclinical Photoacoustic Imaging Systems Examples Figure 10. Preclinical Magnetic Particle Imaging (MPI) Systems Examples Figure 11. Global Preclinical Imaging Consumption Value by Application, (USD Million), 2020 & 2024 & 2031 Figure 12. Global Preclinical Imaging Revenue Market Share by Application in 2024 Figure 13. Hospitals Examples Figure 14. Diagnostics Centers Examples Figure 15. Others Examples Figure 16. Global Preclinical Imaging Consumption Value, (USD Million): 2020 & 2024 & 2031 Figure 17. Global Preclinical Imaging Consumption Value and Forecast (2020-2031) & (USD Million) Figure 18. Global Preclinical Imaging Sales Quantity (2020-2031) & (K Units) Figure 19. Global Preclinical Imaging Price (2020-2031) & (USD/Unit) Figure 20. Global Preclinical Imaging Sales Quantity Market Share by Manufacturer in 2024 Figure 21. Global Preclinical Imaging Revenue Market Share by Manufacturer in 2024 Figure 22. Producer Shipments of Preclinical Imaging by Manufacturer Sales ($MM) and Market Share (%): 2024 Figure 23. Top 3 Preclinical Imaging Manufacturer (Revenue) Market Share in 2024 Figure 24. Top 6 Preclinical Imaging Manufacturer (Revenue) Market Share in 2024 Figure 25. Global Preclinical Imaging Sales Quantity Market Share by Region (2020-2031) Figure 26. Global Preclinical Imaging Consumption Value Market Share by Region (2020-2031) Figure 27. North America Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 28. Europe Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 29. Asia-Pacific Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 30. South America Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 31. Middle East & Africa Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 32. Global Preclinical Imaging Sales Quantity Market Share by Type (2020-2031) Figure 33. Global Preclinical Imaging Consumption Value Market Share by Type (2020-2031) Figure 34. Global Preclinical Imaging Average Price by Type (2020-2031) & (USD/Unit) Figure 35. Global Preclinical Imaging Sales Quantity Market Share by Application (2020-2031) Figure 36. Global Preclinical Imaging Revenue Market Share by Application (2020-2031) Figure 37. Global Preclinical Imaging Average Price by Application (2020-2031) & (USD/Unit) Figure 38. North America Preclinical Imaging Sales Quantity Market Share by Type (2020-2031) Figure 39. North America Preclinical Imaging Sales Quantity Market Share by Application (2020-2031) Figure 40. North America Preclinical Imaging Sales Quantity Market Share by Country (2020-2031) Figure 41. North America Preclinical Imaging Consumption Value Market Share by Country (2020-2031) Figure 42. United States Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 43. Canada Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 44. Mexico Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 45. Europe Preclinical Imaging Sales Quantity Market Share by Type (2020-2031) Figure 46. Europe Preclinical Imaging Sales Quantity Market Share by Application (2020-2031) Figure 47. Europe Preclinical Imaging Sales Quantity Market Share by Country (2020-2031) Figure 48. Europe Preclinical Imaging Consumption Value Market Share by Country (2020-2031) Figure 49. Germany Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 50. France Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 51. United Kingdom Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 52. Russia Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 53. Italy Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 54. Asia-Pacific Preclinical Imaging Sales Quantity Market Share by Type (2020-2031) Figure 55. Asia-Pacific Preclinical Imaging Sales Quantity Market Share by Application (2020-2031) Figure 56. Asia-Pacific Preclinical Imaging Sales Quantity Market Share by Region (2020-2031) Figure 57. Asia-Pacific Preclinical Imaging Consumption Value Market Share by Region (2020-2031) Figure 58. China Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 59. Japan Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 60. South Korea Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 61. India Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 62. Southeast Asia Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 63. Australia Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 64. South America Preclinical Imaging Sales Quantity Market Share by Type (2020-2031) Figure 65. South America Preclinical Imaging Sales Quantity Market Share by Application (2020-2031) Figure 66. South America Preclinical Imaging Sales Quantity Market Share by Country (2020-2031) Figure 67. South America Preclinical Imaging Consumption Value Market Share by Country (2020-2031) Figure 68. Brazil Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 69. Argentina Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 70. Middle East & Africa Preclinical Imaging Sales Quantity Market Share by Type (2020-2031) Figure 71. Middle East & Africa Preclinical Imaging Sales Quantity Market Share by Application (2020-2031) Figure 72. Middle East & Africa Preclinical Imaging Sales Quantity Market Share by Country (2020-2031) Figure 73. Middle East & Africa Preclinical Imaging Consumption Value Market Share by Country (2020-2031) Figure 74. Turkey Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 75. Egypt Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 76. Saudi Arabia Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 77. South Africa Preclinical Imaging Consumption Value (2020-2031) & (USD Million) Figure 78. Preclinical Imaging Market Drivers Figure 79. Preclinical Imaging Market Restraints Figure 80. Preclinical Imaging Market Trends Figure 81. Porters Five Forces Analysis Figure 82. Manufacturing Cost Structure Analysis of Preclinical Imaging in 2024 Figure 83. Manufacturing Process Analysis of Preclinical Imaging Figure 84. Preclinical Imaging Industrial Chain Figure 85. Sales Channel: Direct to End-User vs Distributors Figure 86. Direct Channel Pros & Cons Figure 87. Indirect Channel Pros & Cons Figure 88. Methodology Figure 89. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.
Validation and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction

01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Perkinelmer Bruker Fujifilm Mediso Milabs MR Solutions Aspect Imaging Li-Cor Biosciences Trifoil Imaging Miltenyi Biotec
Related Reports
Purchase Options
Add To Cart
Buy Now
- Digging deeper into global industry information and providing market strategies.Contact Us >>





